BOSTON, Sept. 30, 2024 -- Aktis Oncology, a clinical-stage biotechnology company pioneering the discovery and development of novel targeted alpha radiopharmaceuticals to treat a broad range of solid tumors, today...
Art Pappas will participate on a panel entitled "Invest Globally: A Framework for Building Great Companies" at the CED's Globalization 2008 Conference
News | 02. 14. 2008
